Clinical Trial Update: Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of radiation therapy and anti-PD-1 antibody in pancreatic cancer is being reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Anti-PD-1 antibody
• Radiation therapy

Snippet

Sponsor: Shixiu Wu | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN